Whitney Smith-Kinnaman

5PUBLICATIONS
38CO-AUTHORS
Molecular targetsNeurogeneticsClinical pharmacology and therapeuticsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 07, 2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.

|Feb 09, 2026
EXOSC3 G191 Variants Trigger System-Wide Recalibration of RNA Processing Machinery.

H R Sagara Wijeratne, Avery M Runnebohm, Monica P Barron

|Sep 26, 2025
Striatal spinophilin enhances D2R interaction with cytosolic proteins to mediate persistent D2R agonist-induced locomotor suppression.

Basant Hens, Whitney R Smith-Kinneman, Emma H Doud

|Jun 12, 2025
EXOSC3 S1-domain variants implicated in PCH1b alter RNA exosome cap subunit abundance and thermal stability disrupting rRNA processing and targeting of AU-rich mRNA.

Avery M Runnebohm, H R Sagara Wijeratne, Monica P Barron

|Mar 19, 2020
RNA Polymerase II CTD phosphatase Rtr1 fine-tunes transcription termination.

Jose F Victorino, Melanie J Fox, Whitney R Smith-Kinnaman

Pageof 1

Frequent Collaborators

4 joint publications

Amber L Mosley

4 joint publications

Emma H Doud

3 joint publications

Sarah A Peck Justice

2 joint publications

Jonah Z Vilseck